Clinical practice audit concerning antimicrobial prophylaxis in paediatric neurosurgery: results from a German paediatric oncology unit

被引:5
|
作者
Weiss, Katja [1 ]
Simon, Arne [1 ]
Graf, Norbert [1 ]
Schoepe, Jakob [2 ]
Oertel, Joachim [3 ]
Linsler, Stefan [3 ]
机构
[1] Univ Hosp Childrens Clin, Paediat Oncol & Haematol, D-66421 Homburg, Saar, Germany
[2] Univ Saarland, Inst Med Biometry Epidemiol & Med Informat, Campus Homburg, Homburg, Saar, Germany
[3] Univ Saarland, Univ Hosp, Sch Med, Dept Neurosurg, Kirrbergerstr Bldg 90, D-66421 Homburg, Saar, Germany
关键词
Paediatric oncology; Neurosurgery; Perioperative antimicrobial prophylaxis; Quality improvement in health care; SURGICAL ANTIBIOTIC-PROPHYLAXIS; HEALTH-CARE; INFECTIONS; HOSPITALS; CHILDREN; SURGERY; STEWARDSHIP; MENINGITIS; CRANIOTOMY; PREVENTION;
D O I
10.1007/s00381-016-3279-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Perioperative antimicrobial prophylaxis (PAP) has been identified as an important target for internal audits, concerning the judicious use of antibiotics. Paediatric oncology patients with brain tumours face an increased risk of surgical site infection (SSI) after neurosurgery and receive routine PAP in this setting. All patients younger than 18 years admitted to the paediatric oncology centre (POC) with a neurosurgical intervention. Systematic audit of routine clinical data is divided in two groups: retrospective (Jan 01, 2012-March 31, 2014) and prospective (April 01, 2014-March 31, 2015) referring to an internal PAP guideline, invented in Jan. 2014). Surveillance of SSI up to 30 days after the operation with standard criteria (Centres for Disease Control and Prevention, USA). In total, 53 neurosurgical operations were analysed in 33 paediatric oncology patients. Twelve patients received more than one operation. The detailed analysis of PAP revealed prophylactic cefuroxim doses about 30 mg/kg instead of 50 mg/kg and no repeated dosing in operations lasting longer than 4 h. In addition, Cefotaxim, which is not indicated as PAP in neurosurgery, was used instead of Cefuroxim (or Ampicillin-Sulbactam) in 23 % of all cases in the retrospective and 18 % of all cases in the prospective audit. PAP for more than 3 doses (> 24 h) was administered in 66 % in the retrospective group and in 60 % in the prospective group (p = n.s.). In both groups, no SSI was detected. This first comprehensive audit of PAP in paediatric oncology patients undergoing neurosurgery outlines significant opportunities to improve clinical practice in terms of correct dosing, the correct choice of the antibiotic, a correct timing schedule and a shorter duration of PAP. In addition, our results illustrate in detail the challenges in clinical practice when an evidence-based approach to improve a standard workflow has to be implemented.
引用
收藏
页码:159 / 169
页数:11
相关论文
共 50 条
  • [21] Histopathological findings in paediatric cardiac explants: Results of 68 cases from a single paediatric pathology unit.
    Sebire, NJ
    Malone, M
    Ramsay, A
    Risdon, RA
    JOURNAL OF PATHOLOGY, 2003, 201 : 41A - 41A
  • [22] Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology
    Jessica E Morgan
    Hadeel Hassan
    Julia V Cockle
    Christopher Lethaby
    Beki James
    Robert S Phillips
    Supportive Care in Cancer, 2017, 25 : 221 - 228
  • [23] Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology
    Morgan, Jessica E.
    Hassan, Hadeel
    Cockle, Julia V.
    Lethaby, Christopher
    James, Beki
    Phillips, Robert S.
    SUPPORTIVE CARE IN CANCER, 2017, 25 (01) : 221 - 228
  • [24] Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology
    Blyth, Christopher C.
    Haeusler, Gabrielle M.
    McMullan, Brendan J.
    Kotecha, Rishi S.
    Slavin, Monica A.
    Clark, Julia E.
    SUPPORTIVE CARE IN CANCER, 2017, 25 (11) : 3289 - 3290
  • [25] Diagnostic and Therapeutic Approach in Paediatric Inflammatory Bowel Diseases: Results from a Clinical Practice Survey
    Bronsky, Jiri
    de Ridder, Lissy
    Ruemmele, Frank M.
    Griffiths, Anne
    Buderus, Stephan
    Hradsky, Ondrej
    Hauer, Almuthe Christina
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2019, 68 (05): : 676 - 683
  • [26] Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology
    Christopher C Blyth
    Gabrielle M Haeusler
    Brendan J McMullan
    Rishi S Kotecha
    Monica A Slavin
    Julia E Clark
    Supportive Care in Cancer, 2017, 25 : 3289 - 3290
  • [27] Analysis and results from a UK national dose audit of paediatric CT examinations
    Worrall, Mark
    Holubinka, Mike
    Havariyoun, Glafkos
    Hodgson, Kirsten
    Edyvean, Sue
    Holroyd, John
    Davis, Anne
    Dunn, Matthew
    Gardiner, Anna
    BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1129):
  • [28] Cross infection on a combined paediatric plastic surgery and burns unit. A clinical and microbiological audit
    Camilleri, IG
    Pedler, SJ
    Murphy, O
    Reid, CA
    BURNS, 1999, 25 (07) : 655 - 658
  • [29] The monitoring of prophylaxis in haemophilia A at a regional paediatric comprehensive care centre: an audit of practice at Birmingham Children's Hospital
    Pryor, R.
    Williams, M.
    Motwani, J.
    Lawson, N.
    Taylor, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 83 - 83
  • [30] BLOOD TRANSFUSION IN PAEDIATRIC ONCOLOGY PATIENTS: A REPORT OF THE AUDIT IN A TERTIARY CARE HOSPITAL FROM INDIA
    Durugappa, T.
    Malhotra, P.
    Thakkar, D.
    Radhakrishnan, N. I. T. A.
    Kalra, M.
    Sachdeva, A.
    Aggarwal, S.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S391 - S391